A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.
about
Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.Prognostic and predictive value of EGFR in head and neck squamous cell carcinomaOvercoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyPrevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
P2860
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A patient-derived somatic muta ...... ximab in head and neck cancer.
@en
type
label
A patient-derived somatic muta ...... ximab in head and neck cancer.
@en
prefLabel
A patient-derived somatic muta ...... ximab in head and neck cancer.
@en
P2093
P2860
P1476
A patient-derived somatic muta ...... ximab in head and neck cancer.
@en
P2093
Colleen N Darnell
El Mustapha Bahassi
Jiang Wang
Keith M Wilson
Peter J Stambrook
Susanne I Wells
Trisha M Wise-Draper
P2860
P304
P356
10.1016/J.EJCA.2013.03.005
P50
P577
2013-04-08T00:00:00Z